SEC Form 4 · accession 0001209191-18-036328
Krystal Biotech, Inc. · KRYS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Suma Krishnan
Officer — Chief Operating Officer · Director · 10% Owner
Period of report
Jun 5, 2018
Accepted (ET)
Jun 7, 2018 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001711279
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 5, 2018 | P | 10,866 | $10.7452 | A | 1,962,328 | D | |
| Common StockF2 | Jun 6, 2018 | P | 13,116 | $11.145 | A | 1,975,444 | D | |
| Common StockF3 | Jun 6, 2018 | P | 1,018 | $12.45 | A | 1,976,462 | D | |
| Common StockF4 | holding | — | — | — | 112,162 | I | By trust | |
| Common StockF5 | holding | — | — | — | 2,011,462 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades ranging from $10.73 to $11.00. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range set forth herein.
- F2This transaction was executed in multiple trades ranging from $11.10 to $12.00. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range set forth herein.
- F3This transaction was executed in multiple trades ranging from $12.11 to $12.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range set forth herein.
- F4Directly beneficially owned by the Krishnan Family Trust. The reporting person and her spouse are each joint beneficial owners of the trust with joint voting and investment control.
- F5Directly beneficially owned by Krish S. Krishnan, the spouse of the reporting person.